Data / Form D filings / Delphinus Medical Technologies, Inc.
Delphinus Medical Technologies, Inc.: Form D filings
Delphinus Medical Technologies, Inc., a biotechnology company in Novi, MI, filed 9 Form D notices with the SEC between 2010 and 2025. The latest, on April 3, 2025, reports $27.6 million sold of a $27.6 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 45525 GRAND RIVER AVENUE, Novi, MI, 48374
- Phone
- (248) 522-9600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1492534
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | Amendment | $27,602,177 | $27,602,177 | 8 | Mar 22, 2024 | sec.gov | |
| Nov 26, 2024 | Amendment | $20,375,000 | $20,375,000 | 8 | Mar 22, 2024 | sec.gov | |
| Apr 5, 2024 | New notice | $15,000,000 | $5,279,445 | $9,720,555 | 1 | Mar 22, 2024 | sec.gov |
| Jun 30, 2023 | New notice | $8,000,000 | $5,000,000 | $3,000,000 | 9 | Jun 20, 2023 | sec.gov |
| Sep 13, 2022 | New notice | $30,406,961 | $30,406,961 | 10 | Aug 30, 2022 | sec.gov | |
| Apr 20, 2017 | New notice | $25,000,000 | $8,229,049 | $16,770,951 | 9 | Apr 13, 2017 | sec.gov |
| Sep 11, 2015 | New notice | $44,999,999 | $39,547,131 | $5,452,868 | 10 | Aug 31, 2015 | sec.gov |
| Oct 12, 2010 | Amendment | $9,550,000 | $7,162,500 | $2,387,500 | 8 | May 14, 2010 | sec.gov |
| May 21, 2010 | New notice | $8,000,000 | $6,000,000 | $2,000,000 | 6 | May 14, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hugo Braun | Director | |
| John Neis | Director | |
| Michael Fulton | Director | |
| Ronald Ho | Director | |
| Rachel Brem | Director | |
| Scott White | Executive Officer, Director | |
| Mark Forchette | Director | |
| Elise Berman | Executive Officer | |
| Michael Gross | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Mar 31, 2025 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Delphinus Medical Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.